Dreamit Health unveils its ninth cohort of startups

new Dreamit Health class

Dreamit Health announced its ninth cohort with seven startups aiming to change the face of healthcare. There is also a new managing director for the program, Adam Dakin, a serial entrepreneur and investor, who has cofounded five health technology companies.

He said that the biggest difference between the challenges he faced as an entrepreneur and what his class members contend with is that the sales cycle for healthcare has become longer and more complex.

“On the front end, what has changed from when I started is that you have to walk through the door with a clear value proposition that links directly to a quantifiable ROI,” Dakin said. “It is not enough to have the buy-in from a clinician… The clinicians can no longer just pound their fists and get what they want.”

The seven startups accepted to the Dreamit Health program include:

Ejenta – which has developed remote monitoring technology for NASA to track the health of astronauts on the International Space Station. Led by Rachna Dhamija, the company developed a predictive analytics tool to detect abnormalities relative to a patient’s medical history, with an eye to chronic conditions. Its technology can also correlate different types of data from wearables such as sleep, weight, activity and blood sugar.

Epharmix – another remote monitoring business. It uses a series of alerts and interactive messages tailored to each of 24 disease states with the goal of reducing avoidable readmissions. Blake Marggraff, the CEO, said Epharmix started with end-stage renal disease. Its initial goal was to reduce readmissions by 5 percent with better care plan adherence and it claims its product surpassed expectations by reducing readmissions by more than 50 percent.

Macro-Eyes – it has developed a way to solve the problem of frequent cancellations and no shows with machine learning and predictive analytics through a product called Sibyl.

PAST – the company’s SaaS offering helps doctors identify patients at risk for opioid addiction and substance abuse with the massive challenge presented by disparate data sets that can undermine the ability of doctors to make the best treatment decisions for their patients.

SafKan – it has developed a medical device to automate the process of earwax removal. It resembles a set of earphones but it uses pulsed irrigation and suction in a one-minute procedure and uses disposable pods that capture the wax.

Mahmee – aims to improve prenatal and postpartum care management. The SaaS offering is made to improve health literacy, reduce readmissions and boost breastfeeding rates by transmitting timely, relevant information to users’ smartphones and providing insight from nutritionists, therapists, social workers and lactation experts.

Karuna – it integrates virtual reality headset into its treatment approach, using visual stimulation and exercise. The goal of the company is to reduce chronic pain while avoiding opioids and surgical intervention.